BBA
IGC icon

Baader Bank Aktiengesellschaft’s IGC Pharma IGC Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,961
Closed -$3.6K – 526
2025
Q3 		$3.6K Buy
+13,961
New +$5.31K ﹤0.01% 479
2024
Q4 		– Sell
-10,533
Closed -$3.17K – 433
2024
Q3 		$3.17K Buy
+10,533
New +$4.22K ﹤0.01% 425

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Baader Bank Aktiengesellschaft's IGC Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of IGC Pharma (IGC) in Q4 2025, closing a stake of 13,961 shares — an estimated $3.6K sold.

Baader Bank Aktiengesellschaft first reported a position in IGC in Q3 2024 and held it in 2 quarters. The position peaked at $3.6K in Q3 2025. 30 funds tracked by Wall St. Rank hold IGC as of Q4 2025.

  • Baader Bank Aktiengesellschaft reported no remaining IGC Pharma position as of Q4 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 13,961 IGC Pharma shares in Q4 2025, an estimated $3.6K.
  • Baader Bank Aktiengesellschaft first reported a position in IGC Pharma in Q3 2024 and held it in 2 quarters.
  • Baader Bank Aktiengesellschaft's IGC Pharma position peaked at $3.6K in Q3 2025.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.